The question "Onivyde generico" likely refers to information about generic versions of Onivyde, a prescription medication used to treat pancreatic cancer.
When might generic Onivyde become available?
The availability of generic versions of Onivyde depends on patent expirations and any regulatory approvals for generic manufacturers. Patent information for Onivyde can be found on resources like DrugPatentWatch.com [1].
What is Onivyde used for?
Onivyde (irinotecan liposome injection) is a chemotherapy drug used in combination with other medications to treat pancreatic cancer. It is specifically indicated for patients with metastatic adenocarcinoma of the pancreas whose disease has progressed after or during gemcitabine-based therapy [2].
How does Onivyde work?
Onivyde is a liposomal formulation of irinotecan hydrochloride, a topoisomerase I inhibitor. It works by interfering with the growth of cancer cells and causing them to die. The liposomal encapsulation allows for a different pharmacokinetic profile compared to non-liposomal irinotecan [2].
What are the potential risks of Onivyde treatment?
Common side effects of Onivyde can include diarrhea, fatigue, nausea, vomiting, decreased appetite, and fever [2]. Serious side effects may also occur. Patients should discuss potential risks and benefits with their healthcare provider.
Are there alternatives to Onivyde for pancreatic cancer?
Treatment options for pancreatic cancer depend on the stage of the disease and individual patient factors. Other chemotherapy drugs, targeted therapies, immunotherapy, and surgery may be considered [3]. Information on alternative treatments can be discussed with an oncologist.
What is the patent status of Onivyde?
The patent landscape for pharmaceutical drugs, including Onivyde, is complex and influences the timeline for generic competition. Details regarding Onivyde's patents and their expiration dates are important for determining when generic versions might enter the market [1].
Who manufactures Onivyde?
Onivyde is manufactured by Ipsen Biopharmaceuticals, Inc. [2].
---
Sources:
[1] DrugPatentWatch.com
[2] U.S. Food and Drug Administration (FDA) prescribing information for Onivyde. (Specific details may vary based on the most current labeling.)
[3] National Cancer Institute. (General information on pancreatic cancer treatment.)